Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds bacterium or component thereof or substance produced...
Patent
1995-06-05
1998-10-13
Degen, Nancy
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds bacterium or component thereof or substance produced...
42419711, 530403, A61K 3940, A61K 39385, C07K 110
Patent
active
058208607
ABSTRACT:
A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine provides polysaccharide-protein moieties and contain (a) a group B Streptococcus polysaccharide conjugated to (b)) a functional derivative of a group B Streptococcus C protein alpha antigen that retains the ability to elicit protective antibodies against group B Streptococcus. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.
REFERENCES:
patent: 4207414 (1980-06-01), Kasper
patent: 4284537 (1981-08-01), Beachey
patent: 4324887 (1982-04-01), Kasper
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4356263 (1982-10-01), Kasper
patent: 4367221 (1983-01-01), Kasper
patent: 4367222 (1983-01-01), Kasper
patent: 4367223 (1983-01-01), Kasper
patent: 4425330 (1984-01-01), Norcross et al.
patent: 4619828 (1986-10-01), Gordon
patent: 4673574 (1987-06-01), Anderson
patent: 4757134 (1988-07-01), Blake et al.
patent: 4761283 (1988-08-01), Anderson
patent: 4789735 (1988-12-01), Frank et al.
patent: 4830852 (1989-05-01), Marburg et al.
patent: 4902506 (1990-02-01), Anderson et al.
patent: 5302386 (1994-04-01), Kasper et al.
patent: 5648241 (1997-07-01), Michel et al.
Paoletti et al. Immunogenicity of Group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons. Infection and Immunity vol. 64 677-679, 1996.
Madoff et al. Maternal immunization of mice with Group B Streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J. Clin. Invest. vol. 94 286-292, 1994.
Givner et al. Pooled human IgG hyperimmune for type III Group B Streptococci: Evaluation against multiple strains in vitro and in experimental disease. J. Infectious Diseases vol. 163 1141-1145, 1991.
Boyer, K.M. et al., "Human IgG Antibody to Group B Streptococcus Type II: Protection in a Mouse Model," Clin. Res. 34(4):962A (1986).
Devi, S.J.N. et al., "Antibodies to immunization of mice with Escherichia coli K92 conjugates: Potential vaccines for groups B and C meningococci and E. coli K1," Proc. Natl. Acad. Sci. USA 88:7175-7179 (Aug. 1991).
Dick, W.E. Jr. and Beurret, M., "Glycoconjugates of Bacterial Carbohydrate Antigens: A Survey and Consideration of Design and Preparation Factors," in Contributions to Microbiology and Immunology. vol. 10, Cruse, J.M. and Lewis R.E. Jr., eds., Karger, Basel, Switzerland (Jul. 1989), pp. 48-114.
Dintzis, R.Z., "Rational Design of Conjugate Vaccines," Pediatr. Res. 32(4):376-385 (Oct. 1992).
Heiman, H.S. and Weisman, L.E., "The Opsonic Antibody Response of Female Rats to Type III Group B Streptococcal Immunization: A Model for Maternal Immunity," Veterin. Immunol. Immunopath. 24:79-89 (Jan. 1990).
Jennings, H.J. et al., "Conformational Aspects Critical to the Immunospecificity of the Type III Group B Streptococcal Polysaccharide," Biochemistry 20(16):4511-4518 (1981).
Jennings, H.J. and Lugowski, C., "Immunochemistry of Groups A, B, and C Meningococcal Polysaccharide-Tetanus Toxoid Conjugates," J. Immunol. 127(3):1011-1018 (1981).
Jennings, H.J. et al., "Structural Determination of the Capsular Polysaccharide Antigen of Type II Group B Streptococcus," J. Biol. Chem. 258(3):1793-1798 (1983).
Jennings, H.J., "Capsular Polysaccharides as Human Vaccines," Advances in Carbohydrate Chemistry and Biochemistry. vol. 41, Tipson, R.S. and Horton, D., eds., Academic Press, NY (1983), pp. 155-208.
Jennings, H.J. and Roy, R., "Enhancement of the Immune Response to the Group B Polysaccharide of Neisseria meningitidis by Means of Its Chemical Modification," in The Pathogenic Neisseriae: Proc. 4th Intl. Symp., Schoolnik, G.K. et al., eds., Am. Soc. Microbiol., Washington, D.C. (1985), pp. 628-632.
Kasper, D.L. et al., "Immunochemical Analysis and Immunogenicity of the Type II Group B Streptococcal Capsular Polysaccharide," J. Clin. Invest. 72:260-269 (1983).
Pappenheimer, A.M. Jr. et al., "An Immunological Study of the Diphtheria Toxin Molecule," Immunochemistry 9:891-906 (1972).
Roy, R. and Pon, R.A., "Efficient Synthesis of .alpha.(2-8)-Linked N-Acetyl and N-Glycolylneuraminic Acid Disaccharides from Colominic Acid," Glycoconjugate J. 7(1):3-12 (Mar. 1990).
Timoney, J.F. et al., "The Genus Streptococcus," Hagan and Bruner's Microbiology and Infectious Diseases of Domestic Animals, 8th Edition, Comstock Publishing Associates, New York (1988), pp. 181-186.
Wessels, M.R. et al., "Structure and Immunochemistry of an Oligosaccharide Repeating Unit of the Capsular Polysaccharide of Type III Group B Streptococcus," J. Biol. Chem. 262(17):8262-8267 (1987).
Wessels, M.R. et al., "Isolation and Characterization of Type IV Group B Streptococcus Capsular Polysaccharide," Infec. Immun. 57(4):1089-1094 (Apr. 1989).
Wessels, M.R. et al., "Structural Determination and Immunochemical Characterization of the Type V Group B Streptococcus Capsular Polysaccharide," J. Biol. Chem. 266(11):6714-6719 (Apr. 1991).
Wessels, M.R. et al., "Immunogenicity and Protective Activity in Animals of a Type V Group B Streptococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine," J. Infect. Dis. 171(4):879-884 (Apr. 1995).
Baker, C. J. and Kasper, D. L., "Group B Streptococcal Vaccines," Rev. Inf. Dis. 7(4):458-467 (1985).
Anderson, B. E. et al., "A Protective Protein Antigen of Rickettsia rickettsii Has Tandemly Repeated, Near-Identical Sequences", Infect. Immun. 58(9):2760-2769 (Sept. 1990).
Avery, O. T. et al., "Chemo-Immunological Studies on Conjugated Carbohydrate-Proteins", J. Exp. Med. 54:437-447 (1931).
Baker, C. J. et al., "Immunization of Pregnant Women With A Polysaccharide Vaccine of Group B Streptococcus", New Eng. J. Med. 319(18):1180-1185 (Nov. 1988).
Baker, C. J., "Immunization to Prevent Group B Streptococcal Disease: Victories and Vexations," J. Inf. Dis. 161(5):917-921 (May 1990).
Bevanger, L. et al., "Complete and Incomplete Ibc Protein Fraction in Group B Streptococci", Acta path. microbiol. scand. Sect. B 87:51-54 (1979).
Bevanger, L. et al., "The Ibc Protein Fraction of Group B Streptococci: Characterization of Protein Antigens Extracted by HCl", Acta path. microbiol. scand. Sect. B. 89:205-209 (1981).
Bevanger, L., "Ibc Proteins as Serotype Markers of Group B Streptococci", Acta path. microbiol. immunol. scand. Sect. B 91:231-234 (1983).
Bevanger, L., "The Ibc Proteins of Group B Streptococci: Isolation of the .alpha. and .beta. Antigens by Immunosorbent Chromatography and Test for Human Serum Antibodies Against the Two Antigens", Acta path. microbiol. immunol. scand. Sect. B 93:113-119 (1985).
Bevanger, L. et al., "Mouse-Protective Antibodies Against the Ibc Proteins of Group B Streptococci", Acta path. microbiol. immunol. scand. Sect. B 93:121-124 (1985).
Bevanger, L. et al., "Characterization of the .alpha. antigen of the c proteins of group B streptococci (GBS) using a murine monoclonal antibody", APMIS 100(1):57-62 (Jan. 1992).
Bittle, J. L. et al., "Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals", Adv. Vet. Sci. Comp. Med. 33:1-63 (Feb. 1989).
Brady, L. J. et al., "Identification of Non-Immunoglobulin A-Fc-Binding Forms and Low-Molecular-Weight Secreted Forms of the Group B Streptococcal .beta. Antigen", Infect. Immun. 57(5):1573-1581 (May 1989).
Cleat, P. H. et al., "Cloning and Expression in Escherichia coli of the Ibc Protein Genes of Group B Streptococci: Binding of Human Immunoglobulin A to the Beta Antigen", Infect. Immun. 55(5):1151-1155 (1987).
Coleman, R. T. et al., "Prevention of Neonatal Group B Streptococcal Infections: Advances in Maternal Vaccine Development", Obst. Gynec. 80(2):301-309 (Aug. 1992).
Dailey, D. C. et al., "The Phenotypically Variable Surface Protein of Trichomonas vaginalis Has a Single, Tandemly Repeated Immunodominant Epitope", Infect. Immun. 59(6):2083-2088 (Jun. 1991).
Enea, V. et al., "DNA Cloning of Plasmodium falciparum Circumsporozoite Gene: Amino Acid Sequence of Repetitive Epitope", Science 225:628-630 (1984).
Feldman, R. G. et al., "The immune response to the group B strept
Ausubel Frederick M.
Kasper Dennis L.
Madoff Lawrence C.
Michel James L.
Brusca John S.
Degen Nancy
The Brigham and Women's Hospital
The General Hospital Corp.
LandOfFree
Conjugate vaccine for group B streptococcus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugate vaccine for group B streptococcus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugate vaccine for group B streptococcus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-310812